5-Bromo-2'-deoxyuridine (BrdU) labelling* of MCF10A cells grown in monoculture (control group) and in co-cultures with normal breast-asscoiated fibroblasts (NAF) and carcinoma-associated fibroblasts (CAF),,,,
Culture,BrdU-labeling indices of MCF10A cells (mean ± standard error of the mean),BrdU-labeling indices of MCF10A cells (group mean ± standard error of the mean),Comparison of BrdU-labeling indices of MCF10A cells between groups (linear regression),
MCF10A (n = 6),30.3 ± 3.0,30.3 ± 3.0,MCF10A vs MCF10A + NAF (P = 0.009),MCF10A + NAF vs MCF10A + CAF (P = 0.501)
NAF-1 + MCF10A (n = 7),21.9 ± 4.2,16.1 ± 2.6 (n = 19),,
NAF-2 + MCF10A (n = 6),10.7 ± 3.6,,,
NAF-3 + MCF10A (n = 6),14.7 ± 5.0,,,
CAF-1 + MCF10A (n = 6),15.2 ± 2.0,18.5 ± 2.5 (n = 19),MCF10A vs MCF10A + CAF (P = 0.024),
CAF-2 + MCF10A (n = 6),15.5 ± 4.2,,,
CAF-3 + MCF10A (n = 5),27.6 ± 5.7,,,
*Assessment by immunocytochemistry,,,,
Figure 4,,,There was variability among NAF cultures among CAF,
